Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model

Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model

Gamithromycin is approved for the treatment and prevention of bovine respiratory disease (BRD), which is caused mainly by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma species. In this study, multiple dosage regimens were administered to the neutropenic mouse lung...

Full description

Bibliographic Details
Main Authors: Qingwen Yang, Xuesong Liu, Chenghuan Zhang, Kang Yong, Alancia Carol Clifton, Huanzhong Ding, Yun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Pharmacology
Subjects:
gamithromycin
lung infection model
Pasteurella multocida
mice
pharmacokinetic/pharmacodynamic
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01090/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01090/full

Similar Items